People are more willing to participate in fitness tracker-based insurance policies when they are in control of their participation.
Academic rigor, journalistic flair
Articles on Health insurance
Displaying 1 - 20 of 74 articles
In just five years, the number of mobile-money accounts in Ghana have jumped six-fold, providing fresh perspective on the country’s digital transformation.
In the US, poverty is measured by income level. But that measure misses many other aspects of poverty – like unemployment, poor health and a lack of health insurance.
A trip to the emergency room can turn expensive fast if the providers are not in your network. That is happening more often, as some doctors choose to opt out of insurance plans. Here's why.
The over-medicalization of back pain is a global concern. New research in Canada shows that people with lower income as well as rural and remote dwellers are less likely to access physiotherapy care.
Two community pharmacists suggest a way for improving the palatability of evidence-based universal pharmacare -- for those working in health insurance, pharmacy and the pharmaceutical industry.
Hospitals are now required to post their prices online. This approach is unlikely to change US health care – but better price transparency tools could actually reduce costs.
Three-quarters of insurance executives believe artificial intelligence will revolutionise the industry within a few years. It promises lower premiums, but brings ethical risks too.
The biggest problem in the Indonesian universal healthcare program is that members' contribution is less than the spending to pay claims for hospitals and other health services.
No longer can young people invest in their education and work their way into secure employment. The health impacts of this job insecurity are profound.
The Trump administration's latest effort to undermine the Affordable Care Act is the expansion of short-term insurance plans. But these shorter plans are also short on real benefits.
Britain's health service will soon cost £200 billion. Don't mope, it's cause for celebration.
Efforts to undo Obamacare went far beyond grass-roots activities, with new research showing that contributions by businesses were significant. Does this signal a change in the political process?
Will Ottawa's new advisory council on pharmacare amount to "just another study," or is a national program truly within reach?
By undermining the ACA, Republicans may be taking away one of the health care system's best tools for improving the lives of those with addiction.
Three business giants, Amazon, Berkshire Hathaway and JPMorgan Chase, announced plans to change health care delivery and insurance as we know it. Here's why that could be a major disruption.
The new rules Kentucky and other states want to impose could leave millions of Americans who benefit from this safety net program uninsured – and resorting to the emergency room for their health care.
Funding for a children's health insurance program ran out at the end of last September. Despite the program's clear benefits, plans to renew it have been caught in partisan bickering.
CVS, which operates nearly 10,000 pharmacies across the country, announced intentions to buy Aetna, the nation's third-largest provider of health insurance. Here's how consumers could be affected.
If Americans become less healthy and have less access to health care, then everyone loses.
Top contributors
-
Assistant Professor of Public Policy, Pennsylvania State University
-
Professor of Health Finance, Weatherhead School of Management & School of Medicine, Case Western Reserve University
-
Lecturer, Public Sector Finance, University of Canberra
-
Professor, Allied Health Research, Melbourne Health, La Trobe University
-
Senior Research Fellow, Centre for Social Research in Health, UNSW
-
Doctoral Student, School of Public Health, University of Michigan
-
Professor, Department of Health Policy, London School of Economics and Political Science
-
Assistant Professor of Economics, University of California, Berkeley
-
Assistant Professor, Texas A&M University School of Public Health, Texas A&M University
-
Professor of Pharmaceutical Development and Regulatory Innovation, Schaeffer Center for Health Policy and Economics, University of Southern California
-
Professor of Health Law and Bioethics, Case Western Reserve University
-
Associate Professor of Health Policy, Management and Behavior, University at Albany, State University of New York
-
Professor of Health Economics, Flinders University
-
Adjunct Associate Professor, Menzies Centre for Health Policy, University of Sydney
-
Professor of Bioethics & Medicine, Sydney Health Ethics, University of Sydney
